MedTrace Logo

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

NCT01897519 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2014-06-06

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

Conditions

  • Cardiothoracic Surgery
  • Vascular Surgery

Interventions

DRUG

Placebo

Placebo infusion

DRUG

ABT-719

Arm 1 lower dose, arm 2 intermediate dose, arm 3 high dose

Sponsors & Collaborators

Principal Investigators

  • Ann Eldred, MD · AbbVie

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States
  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01897519 on ClinicalTrials.gov